Aortic pulse wave velocity measurement in systemic sclerosis patients

Reumatismo

Volumn 64, Issue 6, 2012, Pages 360-967

  Colaci, M ^a   Giuggioli, D ^a   Manfredi, A ^a   Sebastiani, M ^a   Coppi, F ^a   Rossi, R ^a   Richeldi, L ^a   Ferri, C ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Arterial stiffness; Pulmonary arterial hypertension; Pulse wave velocity; Scleroderma; Systemic sclerosis

Indexed keywords

CENTROMERE ANTIBODY;

ADULT; ARTERIAL STIFFNESS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE DURATION; ECHOCARDIOGRAPHY; FEMALE; HEART ATRIUM ENLARGEMENT; HEART VENTRICLE HYPERTROPHY; HUMAN; LUNG ARTERY PRESSURE; PULSE WAVE; SYSTEMIC SCLEROSIS; SYSTOLIC BLOOD PRESSURE;

EID: 84872020797     PISSN: 00487449     EISSN: None     Source Type: Journal    
DOI: 10.4081/reumatismo.2012.360     Document Type: Article

References (27)

1. Kahaleh MB, LeRoy EC. Autoimmunity and vascular involvement in systemic sclerosis (SSc). Autoimmunity. 1999; 31: 195-214.
2. Herrick AL. Vascular function in systemic sclerosis. Curr Opin Rheumatol. 2000; 12: 527-33.
3. Wigley FM. Vascular disease in scleroderma. Clinic Rev Allerg Immunol. 2009; 36: 150-75.
4. Belch JJ, McSwiggan S, Lau C. Macrovascular disease in systemic sclerosis: the tip of an iceberg? Rheumatology. 2008; 47 (Suppl. 5): v16-7.
5. Ho M, Veale D, Eastmond C, et al. Macrovascular disease and systemic sclerosis. Ann Rheum Dis. 2000; 59: 39-43.
6. Mok MY, Chiu SS, Lo Y, et al. Coronary atherosclerosis using computed tomography coronary angiography in patients with systemic sclerosis. Scand J Rheumatol. 2009; 38: 381-5.
7. Bartoli F, Blagojevic J, Bacci M, et al. Flowmediated vasodilation and carotid intima-media thickness in systemic sclerosis. Ann N Y Acad Sci. 2007; 1108: 283-90.
8. Cypiene A, Laucevicius A, Venals A, et al. The impact of systemic sclerosis on arterial wall stiffness parameters and endothelial function. Clin Rheumatol. 2008; 27: 1517-22.
9. Soltész P, Dér H, Kerekes G, et al. A comparative study of arterial stiffness, flow-mediated vasodilation of the brachial artery, and the thickness of the carotid artery intima-media in patients with systemic autoimmune diseases. Clin Rheumatol. 2009; 28: 655-62.
10. Timár O, Soltész P, Szamosi S, et al. Increased arterial stiffness as the marker of vascular involvement in systemic sclerosis. J Rheumatol. 2008; 35: 1329-33.
11. Moyssakis I, Gialafos E, Vassiliou V, et al. Aortic stiffness in systemic sclerosis is increased independently of the extent of skin involvement. Rheumatology. 2005; 44: 251-4.
12. Park JH, Sung YK, Bae SC, et al. Ulnar artery vasculopathy in systemic sclerosis. Rheumatol Int. 2009; 29: 1081-6.
13. Cheng KS, Tiwari A, Boutin A, et al. Carotid and femoral arterial wall mechanics in scleroderma. Rheumatology. 2003; 42: 1299-305.
14. Hirata K, Kawakami M, Rourke MF. Pulse wave analysis and pulse wave velocity - a review of blood pressure interpretation 100 years after Korotkov. Circ J. 2006; 70: 1231-9.
15. DeLoach SS, Townsend RR. Vascular stiffness: its measurement and significance for epidemiologic and outcome studies. Clin J Am Soc Nephrol. 2008; 3: 184-92.
16. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum. 1980; 23: 581-90.
17. Lang RM, Bierig M, Devereux RB, et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005; 18: 1440-63.
18. The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J. 2009; 30: 2493-537.
19. LeRoy EC, Black C, Fleischmajer R, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol. 1988; 15: 202-5.
20. Wigley FM, Wise RA, Miller R, et al. Anticentromere antibody as a predictor of digital ischemic loss in patients with systemic sclerosis. Arthritis Rheum. 1992; 35: 688-93.
21. Herrick AL, Heaney M, Hollis S, et al. Anticardiolipin, anticentromere and anti-Scl-70 antibodies in patients with systemic sclerosis and severe digital ischaemia. Ann Rheum Dis. 1994; 53: 540-2.
22. Youssef P, Brama T, Englert H, et al. Limited scleroderma is associated with increased prevalence of macrovascular disease. J Rheumatol. 1995; 22: 469-72.
23. Wan MC, Moore T, Hollis S, et al. Ankle brachial pressure index in systemic sclerosis: influence of disease subtype and centromere antibody. Rheumatology. 2001; 40: 1102-5.
24. Vlachopoulos C, Aznaouridis K, Stefanadis C. Prediction of cardiovascular events and allcause mortality with arterial stiffness: a systematic review and meta-analysis. J Am Coll Cardiol. 2010; 55: 1318-27.
25. Laurent S, Boutouyrie P. Arterial stiffness: a new surrogate end point for cardiovascular disease? J Nephrol. 2007; 20 (Suppl 12): S45-50.
26. Rider OJ, Tayal U, Francis JM, et al. The Effect of Obesity and Weight Loss on Aortic Pulse Wave Velocity as Assessed by Magnetic Resonance Imaging. Obesity. 2010; 18: 2311-6.
27. Vaja V, Ochodnicky P, Krenek P, et al. Rapid large artery remodeling following the administration and withdrawal of calcium channel blockers in spontaneously hypertensive rats. Eur J Pharmacol. 2009; 619: 85-91.